Oral Evidence
Taken before the Science and Technology Committee
on Monday 28 February 2011
Members present:
Andrew Miller (Chair)
| Gavin Barwell | Pamela Nash
|
| Stephen McPartland | Graham Stringer
|
| Stephen Mosley | Roger Williams
|
________________
CONTENTS
Examination of Witnesses
Witnesses: Dr Richard Barker, Director General,
Association of the British Pharmaceutical Industry, and Dr David M Hollinshead,
Royal Society of Chemistry, Science Policy Director, AstraZeneca,
gave evidence.
Question Numbers
1-32
Examination of Witnesses
Witnesses: Dr Olivier Brandicourt, President and
General Manager of Pfizer's Primary Care Business Unit, and co-chair
of the company's Portfolio Strategy and Investment Committee,
Dr Rod MacKenzie, Senior Vice President and Head of Worldwide
Research for PharmaTherapeutics Research and Development, Dr Ruth McKernan,
Senior Vice President and Site Head, Sandwich, and Chief Scientific
Officer for Pfizer Regenerative Medicine, and Richard Blackburn,
Managing Director, Pfizer UK, gave evidence.
Question Numbers
33-119
|